Interaction between Insulin and AT1 receptor. Relevance for hypertension and arteriosclerosis

Basic Research in Cardiology

Volumn 93, Issue 2 SUPPL., 1998, Pages 135-139

  Nickenig, G ^a   Bohm M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Arteriosclerosis; AT1 receptor; Hypertension; Insulin; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; INSULIN; ANGIOTENSIN RECEPTOR;

ANIMAL CELL; ARTERIOSCLEROSIS; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; HYPERTENSION; INSULIN RESISTANCE; NONHUMAN; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYNDROME X; VASOCONSTRICTION; ANIMAL; HUMAN; METABOLIC DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNDROME; UPREGULATION;

ANIMALS; ARTERIOSCLEROSIS; HUMANS; HYPERTENSION; INSULIN; METABOLIC DISEASES; RECEPTORS, ANGIOTENSIN; SYNDROME; UP-REGULATION;

EID: 0032253847     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aguilera G, Catt K (1981) Regulation of vascular angiotensin II receptors during altered sodium intake. Circ Res 49: 751-758 (Pubitemid 11018800)
2. Belluci A, Wilkes BM (1989) Mechanism of sodium modulation of glomerular angiotensin receptors in the rat. Circ Res 49: 751-758
3. Castelli WP, Anderson K (1986) A population at risk. Prevalence of high cholesterol levels in hyertensive patients in the Framingham study. Am J Med 80 (suppl. 2A): 23-32 (Pubitemid 16131300)
4. Castelli WP, Garrison RJ, Wilson PWF, Abbot RD, Kalouscham S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA 256 (20): 2835-2838 (Pubitemid 17178361)
5. Dzau VJ, Burt DW, Pratt RE (1988) Molecular biology of the renin-angiotensin system. Am J Physiol 255: 563-573
6. Griendling KK, Murphy TJ, Alexander RW (1993) Molecular biology of the Renin- Angiotensin System. Circulation 87: 1816-1828 (Pubitemid 23165623)
7. Griendling KK, Lassegue B, Murphy TJ, Alexander RW (1994) Angiotensin II receptor pharmacology. Academic press. Advances in Pharmacol. Vol 28: 269-306
8. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK (1995) Angiotensin II down regulates the vascular smooth muscle AT1 receptor by transcriptional and posttranscriptional mechanisms: evidence for homologuos and heterologous regulation. Mol Pharmacol 48: 601-609
9. Lithell HO (1996) Hyperinsulinemia, insulin resistance and the treatment of hypertension. Am J Hypertens 9: 150S- 154S (Pubitemid 26383509)
10. Mukoyama M, Nakajima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ (1993) Expression cloning of type 2 angiotensin II receptor of a unique class of seven membrane receptors. J Biol Chem 268: 24539-24542 (Pubitemid 23335456)
11. MurphyTJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233-236 (Pubitemid 21896571)
12. Murphy TJ, Takeuchi K, Alexander RW (1992) Molecular cloning of AT1 angiotensin receptors. Am J Hypertens 5: 236-242
13. Nickenig G, Murphy TJ (1996) Enhanced AT1 receptor mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol Pharmacol 50: 743-751 (Pubitemid 26347693)
14. Nickenig G, Strehlow K, Roeling J, Zolk O, Knorr A, Böhm M (1998) Salt Induces Vascular AT1 receptor Overexpression in vitro and in vivo. Hypertension, in press
15. Nickenig G, Murphy TJ (1994) Downregulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol Pharmacol 46: 653-659 (Pubitemid 24334755)
16. Nickenig G., Sachinidis A, Michaelsen F, Böhm M, Seewald S, Vetter H (1997) Up-Regulation of Vascular Angiotensin II Receptor Gene Expression by Low Density Lipoprotein in Vascular Smooth Muscle Cells. Circulation 95: 473-478 (Pubitemid 27056216)
17. Nickenig G, Jung O, Strehlow K, Zolk O, Linz W, Schölkens BA, Böhm M (1997) Hypercholesterolemia is associated with enhanced angiotensin AT1 Receptor expression. Am J Physiol 272: H2701-2707
18. Regenauer A (1996) Prognostische Aspekte des metabolischen Syndroms. Versicherungsmedizin 48: 161-169
19. Rett K, Wicklmayr M, Standl E (1994) Das metabolische Syndrom. Wien Klin Wochenschr 106: 750-757
20. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T (1991) Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 351: 230-232
21. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T (1995) The angiotensin AT2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657
22. Stout RW (1996) Hyperinsulinemia and atherosclerosis. Diabetes 45: 45-46
23. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251 (Pubitemid 23191415)
24. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR (1996) Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93 (22) 12490-5 (Pubitemid 26367171)
25. Yamada T, Horiuchi M, Dzau VJ (1996) Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 93: 150-160
26. Nickenig G, Röling J, Strehlow K, Schnabel P, Böhm M (1998) Insulin Induces Up- Regulation of Vascular AT1 Receptor Gene Expression by Posttranscriptional Mechanisms. Circulation, in press